Insider Transactions in Q4 2025 at Edwards Lifesciences Corp (EW)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2025
|
Heisz Leslie Stone Director |
SELL
Open market or private sale
|
Direct |
2,615
-7.79%
|
$217,045
$83.41 P/Share
|
|
Dec 12
2025
|
Daniel J. Lippis CVP, JAPAC |
SELL
Open market or private sale
|
Direct |
1,019
-4.43%
|
$85,596
$84.03 P/Share
|
|
Dec 12
2025
|
Daniel J. Lippis CVP, JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,019
+4.24%
|
$60,121
$59.26 P/Share
|
|
Dec 12
2025
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Bona fide gift
|
Direct |
7,100
-18.22%
|
-
|
|
Dec 12
2025
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,386
-12.02%
|
$945,038
$83.76 P/Share
|
|
Dec 11
2025
|
Daveen Chopra CVP, TMTT & Surgical |
SELL
Open market or private sale
|
Direct |
2,000
-5.85%
|
$168,000
$84.38 P/Share
|
|
Dec 10
2025
|
Bernard J Zovighian CEO |
SELL
Open market or private sale
|
Indirect |
3,863
-31.01%
|
$320,629
$83.45 P/Share
|
|
Dec 10
2025
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,340
-18.38%
|
$941,220
$83.83 P/Share
|
|
Dec 10
2025
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,340
+15.53%
|
$669,060
$59.26 P/Share
|
|
Dec 09
2025
|
Bernard J Zovighian CEO |
BUY
Bona fide gift
|
Indirect |
3,863
+23.67%
|
-
|
|
Dec 09
2025
|
Bernard J Zovighian CEO |
SELL
Bona fide gift
|
Direct |
3,863
-4.55%
|
-
|
|
Dec 09
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,700
-16.18%
|
$646,800
$84.47 P/Share
|
|
Dec 09
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,700
+13.92%
|
$454,300
$59.26 P/Share
|
|
Dec 08
2025
|
Bernard J Zovighian CEO |
SELL
Open market or private sale
|
Direct |
21,487
-20.21%
|
$1,826,395
$85.21 P/Share
|
|
Dec 08
2025
|
Bernard J Zovighian CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,350
+19.25%
|
$1,495,650
$59.26 P/Share
|
|
Dec 08
2025
|
Wayne Markowitz CVP, JAPAC |
SELL
Open market or private sale
|
Direct |
583
-3.21%
|
$50,138
$86.01 P/Share
|
|
Nov 13
2025
|
Andrew M. Dahl SVP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
1,160
+11.22%
|
-
|
|
Nov 10
2025
|
Daniel J. Lippis CVP, JAPAC |
SELL
Open market or private sale
|
Direct |
1,020
-4.43%
|
$83,640
$82.55 P/Share
|
|
Nov 10
2025
|
Daniel J. Lippis CVP, JAPAC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,020
+4.24%
|
$60,180
$59.26 P/Share
|
|
Nov 10
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,000
-12.85%
|
$1,079,000
$83.16 P/Share
|
|
Nov 10
2025
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,000
+19.73%
|
$767,000
$59.26 P/Share
|